Stay updated on IRX-2 Regimen and Durvalumab Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Regimen and Durvalumab Clinical Trial page.

Latest updates to the IRX-2 Regimen and Durvalumab Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry (v3.6.3) was added to the record history, updating the study record's version from the previous v3.6.2 and indicating an administrative update to the record.SummaryDifference0.1%

- Check23 days agoChange DetectedA new revision label 'Revision: v3.6.2' was added to the record history and the previous label 'Revision: v3.6.0' was removed, updating the page's version history metadata.SummaryDifference0.1%

- Check38 days agoChange DetectedA new revision v3.6.0 is added and the previous v3.5.5 revision is removed. The page now includes a notice that the study is no longer looking for participants, indicating recruitment has closed.SummaryDifference0.3%

- Check45 days agoChange DetectedA new revision entry, v3.5.5, was added and the previous entry, v3.5.4, was removed. This reflects a minor update to the page's revision history.SummaryDifference0.1%

- Check67 days agoChange DetectedThe record history now shows a new revision entry, updating from v3.5.3 to v3.5.4. This reflects an incremental update to the page's revision metadata and change tracking.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page’s interface/version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a backend/site software revision rather than a change to the ClinicalTrials.gov record history.SummaryDifference0.1%

Stay in the know with updates to IRX-2 Regimen and Durvalumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen and Durvalumab Clinical Trial page.